Enanta management to participate in two September investor conferences
Enanta Pharmaceuticals said members of management will participate in two investor conferences in September, with live webcasts of each conference.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in two investor conferences in September:A live webcast of each…